Sarah Zielsdorf, MD, MS – Polymicrobial Sepsis – 2022 Conference (LDN; low dose naltrexone)
Sarah Zielsdorf, MD, MS – Polymicrobial Sepsis – 2022 Conference (LDN; low dose naltrexone)
Sarah Zielsdorf, MD, MS – Hashimoto’s Thyroiditis – 2022 Conference (LDN; low dose naltrexone
Sarah Zielsdorf, MD, MS – Hashimoto’s Thyroiditis – 2022 Conference (LDN; low dose naltrexone)
Sarah Zielsdorf, MD, MS – Attenuating Viral Pathogenesis with TLR and VitD Receptor Therapeutics – 2022 Conference (LDN; low dose naltrexone)
Sarah Zielsdorf, MD, MS – Attenuating Viral Pathogenesis with TLR and VitD Receptor Therapeutics – 2022 Conference (LDN; low dose naltrexone)
Leonard Weinstock, MD – Crohn’s Disease and Ulcerative Colitis – 2022 Conference (LDN; low dose naltrexone)
Leonard Weinstock, MD – Crohn’s Disease and Ulcerative Colitis – 2022 Conference (LDN; low dose naltrexone)
Huong Mai Tran, PharmD – Psoriasis – 2022 Conference (LDN; low dose naltrexone)
Huong Mai Tran, PharmD – Psoriasis – 2022 Conference (LDN; low dose naltrexone)
Christian Stella, PharmD, ABAAHP, FAAMM – LDN For Depression – 2022 Conference (LDN; low dose naltrexone)
Christian Stella, PharmD, ABAAHP, FAAMM – LDN For Depression – 2022 Conference (LDN; low dose naltrexone)
Pamela Smith, MD, MPH, MS – Insulin Resistance & Diabetes – 2022 Conference (LDN; low dose naltrexone)
Pamela Smith, MD, MPH, MS – Insulin Resistance & Diabetes – 2022 Conference (LDN; low dose naltrexone)
Armin Schwarzbach, MD, PhD – Lyme Testing – 2022 Conference (LDN; low dose naltrexone)
Armin Schwarzbach, MD, PhD – Lyme Testing – 2022 Conference (LDN; low dose naltrexone)
Yusuf Saleeby, MD – LDN Basics – 2022 Conference (LDN; low dose naltrexone)
Yusuf Saleeby, MD – LDN Basics – 2022 Conference (LDN; low dose naltrexone)
Masoud Rashidi, PharmD – LDN, ULDN for Pain – 2022 Conference (LDN; low dose naltrexone)
Masoud Rashidi, PharmD – LDN, ULDN for Pain – 2022 Conference (LDN; low dose naltrexone)